Community/Retail

Voluntary reports indicate that some individuals, especially youth and young adults, are experiencing seizures or convulsions following use of e-cigarettes, although a definitive link has not been established.

If approved, Gimoti would be the first non-oral drug treatment for symptoms associated with acute and recurrent diabetic gastroparesis in adult women and would represent the first significant advancement in the treatment of gastroparesis in 40 years.

The warning letters issued to azmedicinalshop.com and thedonrx.net request that these enterprises immediately cease offering violative drugs for sale to consumers in the United States.

Mary Koslap‐Petraco DNP, PNPPC‐BC, CPNP, FAANP of Stony Brook University School of Nursing and Pediatric Nurse Practitioner House Calls advises nurses to listen to concerned parents and assure them they want the best for their children.

Immune Globulin Intravenous, Human – slra 10% Liquid (Asceniv) is indicated for use in the treatment of primary humoral immunodeficiency disease in adults and adolescents.

A study found that student pharmacists who had improv coursework included in their curriculum refined their communication skills.

The combination treatment (Duaklir, Circassia) is designed to be administered twice-daily via AstraZeneca’s breath-actuated inhaler (Pressair).

Avaclyr 3%, a herpes simplex virus nucleoside analog DNA polymerase inhibitor.

In addition to concerns about contamination, some products made by these companies that are labeled as homeopathic do not deliver any benefit, yet may potentially be harmful, according to the FDA.

The CBD-related items include non-THC containing topical creams, patches and sprays.

Why did this patient's warfarin dose triple?

Benzodiazepines are involved in over 30% of opioid overdoses. It is important to learn about this combination and how to counsel patients.

This article will describe the unusual discovery of 5 commonly prescribed medications, many of which were through serendipitous events.

Cladribine (Mavenclad, EMD Serono) is the first oral multiple sclerosis drug to demonstrate 2 years of proven efficacy with a maximum of 20 days of treatment.

Study data suggest the drug helps reduce the risk of major adverse cardiovascular event in certain patients.

The goals are to assess the candidate’s safety and to determine if the vaccination induces the human immune system to produce proteins called neutralizing antibodies.

Each year, the American Pharmacists Association presents this award awarded to a professional who goes above and beyond the call of duty.

The National Rosacea Society (NRS) has designated April as Rosacea Awareness month to improve education of rosacea.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

With this approval, certolizumab pegol becomes the first FDA-approved therapy for this type of axSpA, filling an unmet clinical need for treatment options, according to the release.

The action follows discontinuation of quinidine, the only FDA-approved intravenous antimalarial drug in the United States.

Aspirin and heroin were discovered within weeks of each other in 1897 by Felix Hoffmann.

ASHP’s Midyear Clinical Meeting rose 5 spots, from No. 157 to No. 152 out of 250 trade shows with the Consumer Electronics Shows (CES) topping the list.

Overall, more than half of commercially insured individuals who initiated pre-exposure prophylaxis persisted with it for the 12-month duration of the cohort study.

The drug is indicated to for men with low testosterone levels due to specific medical conditions, such as genetic disorders, including Klinefelter syndrome or tumors that have damaged the pituitary gland.

The acquisition of Wellcare Health Plans will create a centralized health care enterprise focused on government-sponsored health care programs on the forefront of Medicaid, Medicare, and the Health Insurance Marketplace for Centene.

Lannett officials said that the company received approval of its Abbreviated New Drug Application (ANDA) for Aspirin and Extended-Release Dipyridamole Capsules, 25 mg/200 mg, a generic version of Aggrenox® Capsules, 25 mg/200 mg (Boehringer Ingelheim Pharmaceuticals).

Oklahoma Attorney General Mike Hunter filed a lawsuit against Purdue Pharma and 3 other manufacturers of opioid pain medications in 2017. In the filing on behalf of the state, he claimed these companies utilized deceptive marketing campaigns over the previous decade, which helped fuel the state’s opioid epidemic.

According to PQA, pharmacist-provided care can transform the pharmacist’s role in health care from a medication dispenser to an indispensable clinical care team member providing affordable, accessible and high-quality health care services that improve patient outcomes.